Home Newsfeeds AMD Says Prudently Controlling Operating Expenses And Headcount Growth

News

AMD Says Prudently Controlling Operating Expenses And Headcount Growth

-Reuters

byBenzinga Newsdesk

November 1, 2022

1 minute read

-Reuters

Molecular Partners Presents Interim Safety And Mechanistic Data From Ongoing Phase 1 Trial Of MP0317 For Treatment of Solid Tumors

By Benzinga Newsdesk

November 10, 2:40 AM

First clinical observation of tumor localized CD40 activation provided by MP0317 No systemic or dose-limiting toxicities observed, a key parameter for CD40 agents Dose escalation remains ongoing with study

MOLN

Methode Electronics, Inc. Announces Preliminary Financial Results For Fiscal 2023; Sees FY23 Revenue $1.183B Vs $1.17B Est.; EPS $2.10-$2.14 Vs $2.51 Est.

By Benzinga Newsdesk

June 12, 4:17 PM

Preliminary Financial Results for Fiscal 2023The company expects to report record net sales of approximately $1,183 million for fiscal 2023, which would represent a two percent increase from the prior fiscal year. This

MEI

Marathon Oil Plans To Sell Part Of Alba Field LNG Produce To Glencore

By Lekha Gupta

October 17, 8:52 AM

Marathon Oil Corp (NYSE: MRO), through its wholly-owned subsidiaries,

GLCNF

Invitae Announces Partnership For Real-World Data Sharing To Inform Rare Cancer Research

By Benzinga Newsdesk

October 27, 7:36 AM

– Using Invitae's Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – –

AZN

AMD Says Prudently Controlling Operating Expenses And Headcount Growth

Related Posts

Molecular Partners Presents Interim Safety And Mechanistic Data From Ongoing Phase 1 Trial Of MP0317 For Treatment of Solid Tumors

Methode Electronics, Inc. Announces Preliminary Financial Results For Fiscal 2023; Sees FY23 Revenue $1.183B Vs $1.17B Est.; EPS $2.10-$2.14 Vs $2.51 Est.

Marathon Oil Plans To Sell Part Of Alba Field LNG Produce To Glencore

Invitae Announces Partnership For Real-World Data Sharing To Inform Rare Cancer Research